Northwest Biotherapeutics Inc. (NWBO)
Market Open
11 Sep, 14:27
OTC PINK OTC PINK Primary 
XSTU $
0. 16
-0
-1.1074%
$
279.37M Market Cap
- P/E Ratio
- Div Yield
207,268 Volume
0 Eps
$ 0.17
Previous Close Investors:
Want to track NWBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Northwest Biotherapeutics Inc. (NWBO) Statistics
Valuation metrics
Market Cap 279.37M
Enterprise value 335.21M
Trailing P/E (ttm) -6.85
Forward P/E -4
PEG ratio -0.07
Price/Sales (ttm) 128.56
Price/Book (mrq) -8.03
Enterprise Value/Revenue 154.26
Enterprise Value/EBITDA -5.82
Overview
Shares outstanding 1.56B
Float 1.57B
Shares short 14.14M
% Held by insiders 0.04%
% Held by institutions 0%
Average volume (10 days) 1.59M
Average volume (90 days) 2.67M
Price summary
52-Week low 0.14
52-Week high 0.34
Beta -0.77
50-Day moving average 0.17
200-Day moving average 0.21
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:16
Last split Date 26 Sep 2012
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -17.36%
Operating margin -23.16%
Operational effectiveness
Return on assets -0.5%
Return on equity 0.7%
Income Statement
Revenue (ttm) 1.38M
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) 1.91%
Gross profit (ttm) -27.41M
EBITDA -57.85M
Net income to common (ttm) -61.48M
Diluted EPS (ttm) -0.02
Quarterly earnings growth (yoy) 1.91%
Balance Sheet
Total cash (mrq) 3.04M
Total cash per share (mrq) 0
Total debt (mrq) 64.83M
Total Debt/Equity (mrq) -1.62
Current ratio (mrq) 0.04%
Book value per share (mrq) -0.02
Cash Flow
Cash flow statement -44.76M
Levered free cash flow (LFCF) -23.95M
